Axovant Sciences

Renamed Axovant could see big gains in 2019: analysts
Fierce Biotech
Fri, 02/8/19 - 10:12 am
Axovant Sciences
Axovant Gene Therapies
small molecule drugs
Focused on rebuilding the pipeline, Axovant’s new crew assembles another preclinical gene therapy deal
Endpoints
Mon, 07/9/18 - 10:55 am
Axovant Sciences
AXO-Lenti-PD
gene therapy
RNAi
Benitec
Top research execs from Teva, Allergan recruited to help lead Axovant out of the R&D wasteland
Endpoints
Tue, 05/29/18 - 08:57 am
Axovant Sciences
R&D
Allergan
Teva Pharmaceutical
The Winners And Losers Of JP Morgan Monday
Forbes
Mon, 01/8/18 - 10:23 pm
JPMHC 2018
Cellular Biomedicine
Alder Biopharmaceuticals
Nevro
Insulet
PTC Therapeutics
Axovant Sciences
Momenta
Natus Medical
Oxford Immunotec
EXACT Sciences
A new Alzheimer’s drug, once worth billions, is headed for the trash
Stat
Mon, 01/8/18 - 11:45 am
Alzheimer's disease
Axovant Sciences
intepirdine
dementia with Lewy bodies
The new Biotech Scorecard: 10 make-or-break industry events for the fourth quarter
Stat
Tue, 10/3/17 - 11:50 am
biotech
Axovant Sciences
intepirdine
SAGE Therapeutics
brexanolone
AbbVie
risankizumab
Global Blood Therapeutics
GBT-440
DBV Technologies
Viaskin Peanut
Cytokinetics
Amicus Therapeutics
ATB200
Spark Therapeutics
Bluebird Bio
Revance Therapeutics
RT002
After Intepirdine Flunked in Alzheimer’s Disease, Is Axovant Sciences a Buy?
Motley Fool
Tue, 10/3/17 - 11:37 am
Axovant Sciences
Alzheimer's disease
intepirdine
Axovant's closely watched Alzheimer's drug fails late-stage trial
BioPharma Dive
Tue, 09/26/17 - 11:36 am
Axovant Sciences
Alzheimer's disease
clinical trials
intepirdine
Duchenne muscular dystrophy
Motley Fool
Thu, 09/21/17 - 10:10 pm
Duchenne Muscular Dystrophy
PTC Therapeutics
Translarna
Axovant Sciences
Alzheimer's disease
NASH
Gilead Sciences
Is This the Next Home-Run Biotech Stock?
Motley Fool
Wed, 06/28/17 - 10:42 pm
biotech
Axovant Sciences
intepirdine
RVT-101
A company developing a drug to treat Alzheimer's disease just got a new CEO — and the stock is jumping
Yahoo/Business Insider
Mon, 04/10/17 - 10:12 pm
Alzheimer's disease
David Hung
Pharma CEOs
Axovant Sciences
Axovant Sinks on Pfizer Alzheimer's Drug Blowup
TheStreet.com
Tue, 02/2/16 - 10:26 am
Axovant Sciences
Pfizer
Alzheimer's disease
PF-05212377
5 Biotech Predictions for 2016
Motley Fool
Sat, 01/9/16 - 10:50 am
biotech
GW Pharma
Medical Marijuana
Big Pharma
Alzheimer's disease
CAR-T
Portola Pharmaceuticals
Eli Lilly
Biogen
Axovant Sciences
Company Run By 30-Year-Old Former Hedge Fund Manager Starts Study To Get Its Alzheimer's Drug Approved
Forbes
Tue, 10/6/15 - 08:12 am
Axovant Sciences
Alzheimer's disease
RVT-101
3 Long Shots Biotech Companies Are Working On
Motley Fool
Sat, 07/11/15 - 10:27 am
biotech
Alzheimer's disease
Parkinson's Disease
Axovant Sciences
RVT 101
GSK
Biogen
aducanumab
Prothena
PRX-002
What You May Have Missed in Biotech: Cholesterol Drug Scrutiny and a Hedge Fund Alzheimer's Play
Forbes
Sat, 06/13/15 - 10:36 am
biotech
GSK
Axovant Sciences
Alzheimer's disease
PCSK9 inhibitors
Praluent
Sanofi
Regeneron
Repatha
Amgen
The 29 Year Old Behind The Giant Biotech IPO That Rose By 90% Speaks
Forbes
Thu, 06/11/15 - 06:11 pm
biotech
IPOs
Axovant Sciences